ENDPOINTS NEWS33m
Dyne de­tails piv­otal plans for my­oton­ic dy­s­tro­phy RNA drug, though da­ta blip wor­ries some in­vestors
Dyne Therapeutics touted an early-stage study of its RNA treatment for myotonic dystrophy type 1 and has selected the dose it ...